Asgard Therapeutics

Investment area
Novo Seeds
Date of investment
November 2021

Asgard Therapeutics is a private biotech company pioneering in vivo direct cell reprogramming approaches to elicit potent anti-cancer immune responses.

Asgard Therapeutics

Investment area
Novo Seeds
Date of investment
November 2021

Asgard Therapeutics is a private biotech company pioneering in vivo direct cell reprogramming approaches to elicit potent anti-cancer immune responses.

Asgard Therapeutics

Investment area
Novo Seeds
Date of investment
November 2021

Asgard Therapeutics is a private biotech company pioneering in vivo direct cell reprogramming approaches to elicit potent anti-cancer immune responses.